Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02451228 · ClinicalTrials.gov registry record

Indomethacin PK and PD Therapy in Pregnancy

A clinical trial of Pregnancy and Premature Birth, sponsored by The University of Texas Medical Branch, Galveston.

Completed
Registry status
62
Enrollment target
6
Study locations

NCT02451228: Completed study of Pregnancy and Premature Birth, sponsored by The University of Texas Medical Branch, Galveston.

NCT02451228 is a study of Pregnancy and Premature Birth that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 62 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02451228, a study of Pregnancy and Premature Birth, has completed, sponsored by The University of Texas Medical Branch, Galveston.

COMPLETED
Registry status
62 participants
Enrollment target
6
Study locations

Study Summary

This study will follow pregnant women who are taking indomethacin as Standard of Care (SOC) for the indications of preterm labor (PTL), short cervix, or other indications, to evaluate the pharmacokinetics (PK), what the body does to the drug, and pharmacodynamics (PD), effectiveness of the drug in treating the specific intended disease process of this medication. This will help us develop more information for medication dosing specific to pregnant women experiencing preterm labor. Indomethacin is often prescribed to pregnant women presenting with preterm labor or shortened cervix, which places them at risk for preterm labor and delivery. Indomethacin has been used since the 1970s to prolong pregnancy by decreasing uterine contractions. However, despite the widespread use of indomethacin in pregnancy, there is limited information available to help physicians determine how much indomethacin to prescribe and how often to prescribe it.

Primary Outcome

Gestational age at delivery calculated from the first day of last menstrual period unless "unsure" and then it will be calculated from ultrasound measurements

Conditions Studied

Pregnancy Premature Birth Premature Labor

Interventions

  • OTHER Serial blood collection

Study Locations (6)

Alabama

  • University of Alabama - Birmingham

Mississippi

  • University of Mississippi Medical Center - Jackson

New York

  • Columbia University - New York

North Carolina

  • Duke University - Durham

Texas

  • University of Texas Medical Branch, Dept of OB/GYN - Galveston

Utah

  • University of Utah - Salt Lake City

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2015-05
Est. Completion 2018-12-31
The University of Texas Medical Branch, Galveston

203 total trials

What the finished NCT02451228 record still lists

NCT02451228 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Serial blood collection is the first listed.

NCT02451228 lists 6 locations in 6 states (Alabama, Mississippi, New York).

Frequently Asked Questions

What is clinical trial NCT02451228 about?

NCT02451228 is a clinical study titled "Indomethacin PK and PD Therapy in Pregnancy". This study will follow pregnant women who are taking indomethacin as Standard of Care (SOC) for the indications of preterm labor (PTL), short cervix, or other indications, to evaluate the pharmacokinetics (PK), what the body does to the drug, and pharmacodynamics (PD), effectiveness of the drug in t...

What is the current status of trial NCT02451228?

This trial is currently completed. The enrollment target is 62 participants. The study started on 2015-05. Estimated completion is 2018-12-31.

What conditions does trial NCT02451228 study?

This clinical trial studies the following conditions: Pregnancy, Premature Birth, Premature Labor.

What interventions are being tested in trial NCT02451228?

The interventions under investigation include: Serial blood collection (OTHER).

Who is sponsoring clinical trial NCT02451228?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02451228 being conducted?

This trial has 6 study locations across Alabama, Mississippi, New York, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02451228's enrollment target sits among peer trials

62 141st of 191 higher than 51 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02451228, the US trial registry maintained by the National Library of Medicine. NCT02451228 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.